Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is Corcept Therapeutics Incorporated (CORT) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
45/100
Does not fit
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to CORT
EBIT/EV yield ≥ 10%
key0.8%
ROIC ≥ 25%
key-1.2%
EV/EBIT ≤ 12
131.9x
Gross margin ≥ 30%
98.3%
How CORT Scores on Other Strategies
Live Financial Snapshot
Market cap
$9.29B
P/E (TTM)
122.0x
ROIC (TTM)
-1.23%
Gross margin
98.25%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is CORT's Joel Greenblatt fit score?
CORT scores 45/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own CORT?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends CORT.
How often is this score updated?
CORT's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends CORT.
